Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Clinical trial NCT03540407 · COMPLETED

Trial details

NCT number: NCT03540407
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Carcinoma Stage II Cervical Carcinoma Stage III Cervical Carcinoma Stage IV Endometrial Adenocarcinoma Stage II Endometrial Adenocarcinoma Stage III Endometrial Adenocarcinoma Stage IV

Start date: 2015-01-07
Primary completion: 2019-02-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.